Is a higher percentage always better in skincare?

Pinnell et al. (2001) measured percutaneous absorption of L-ascorbic acid across a range of concentrations using a validated porcine skin model. Skin tissue levels increased with concentration up to approximately 20%, then plateaued — additional concentration produced no further increase in tissue deposition. At concentrations above 20%, the free-acid fraction that remains on the surface (and in the formula) increases oxidative instability: L-ascorbic acid oxidises more rapidly, shortening product shelf life and potentially generating pro-oxidant intermediates. The clinical sweet spot documented in human trials is 10–20%, not the maximum achievable formulation concentration.

• Study Pinnell et al. (2001) showed that skin tissue levels of L-ascorbic acid plateau at ~20% — concentrations above this do not increase absorption but do increase stability challenges. ¹
• Study L-ascorbic acid requires pH ≤ 3.5 and concentration ≥ 8% for meaningful percutaneous absorption; at 20% tissue saturation is reached after ~3 daily applications. ¹
• Review Chemical stability of ascorbic acid in consumer products is highly concentration- and formulation-dependent; higher free-acid concentrations increase oxidative degradation rate. ²

The clinical literature on niacinamide converges on 2–5% as the effective range for its primary endpoints. Bissett et al.'s anti-aging studies used 5% and demonstrated improvements in yellowing, fine lines, and hyperpigmentation. Sebum regulation data (Draelos et al., 2006) used 2%. The CIR Expert Panel noted that tolerability concerns — while not severe — are more likely above 5%. No published dose-response study has demonstrated superior efficacy for niacinamide concentrations above 5% for any widely studied endpoint. Products marketed at 10–20% niacinamide are trading on association with higher percentages, not on clinical evidence of incremental benefit above 5%.

• Study Bissett et al. (2004, 2005) clinical trials of 5% topical niacinamide demonstrated improvements in yellowing, blotchiness, fine lines, and hyperpigmentation; these are the most frequently replicated anti-aging concentrations in the literature. ⁴
• Study Bissett et al. (2005) confirmed the 5% endpoint package in a separate clinical study, providing the strongest evidence base for niacinamide anti-aging claims. ⁵
• Study Draelos et al. (2006) demonstrated sebum regulation and pore improvement at 2% niacinamide — below the 5% anti-aging threshold. ⁶
• CIR The CIR Expert Panel found niacinamide safe as used in cosmetics, with no serious adverse events, but the formal safety update has not been performed for concentrations substantially above 5% in long-term controlled trials. ⁷

Both actives illustrate the classic concentration-response asymmetry in topical dermatology: efficacy plateaus before tolerability does. For L-ascorbic acid at pH ≤ 3.5, stinging and transient erythema are common and worsen with concentration, even though tissue uptake does not increase above 20%. For niacinamide, the risk of niacin-impurity-related sensitivity is a quality-control (concentration-amplified) issue. Choosing a formulation at the evidence-backed concentration ceiling delivers the documented clinical benefit with the lower irritation burden — the opposite of what 'more is better' implies.

• Review At pH below 3.5, irritation, stinging, and transient erythema from L-ascorbic acid are well-documented and worsen with higher concentration, even though absorption does not increase above the 20% tissue saturation ceiling. ³
• CIR Occasional niacinamide sensitivity is more likely attributable to niacin (nicotinic acid) contamination of the raw material — a quality-control issue that is proportional to the dose applied — than to intrinsic niacinamide properties. ⁷

The absorption plateau data for L-ascorbic acid comes from a single porcine skin model study. Independent human replication of the 20% saturation threshold has not been published. For niacinamide, almost all clinical anti-aging data (the 5% endpoint package) originates from Procter & Gamble-affiliated researchers; independent academic replication is limited. No published dose-response study has systematically compared niacinamide concentrations above 5% against 5% with blinded outcome assessment. The ceiling concentrations cited here are the best-supported by currently available evidence — not necessarily the final word.

• Study All percutaneous absorption data establishing the 20% saturation ceiling for L-ascorbic acid comes from a single porcine skin model study; human replication of the saturation threshold has not been independently published. ¹
• Study Nearly all Bissett et al. clinical data establishing 5% niacinamide anti-aging claims is from Procter & Gamble-affiliated research; independent academic replication is limited. ⁵

Is 20% vitamin C better than 15%?

Not in terms of skin tissue uptake. Pinnell et al. (2001) showed that L-ascorbic acid tissue levels plateau at approximately 20% — concentrations above this do not increase absorption. At 20% vs 15%, you may increase irritation and stability issues without gaining additional clinical benefit. ¹

Does higher niacinamide percentage (10%, 20%) work better than 5%?

There is no published clinical evidence that niacinamide above 5% delivers superior results for brightening, anti-aging, or sebum regulation compared to 5%. The most robustly studied concentration is 5%, and the CIR safety review has not been formally updated for long-term use at substantially higher concentrations. ⁴⁵⁷

What is the effective concentration for L-ascorbic acid?

The effective range with meaningful percutaneous absorption is 8–20%, at pH ≤ 3.5. Below 8% clinical benefit is modest. At 20%, skin tissue saturates after roughly three daily applications. Concentrations above 20% do not increase tissue uptake. ¹

What is the effective concentration for niacinamide?

2–5%. Sebum regulation was demonstrated at 2%; brightening and anti-aging endpoints have the strongest evidence at 5%. No peer-reviewed dose-response study has demonstrated superior efficacy above 5% for any commonly studied endpoint. ⁶⁴⁵

1. 1

   Topical L-ascorbic acid: percutaneous absorption studies

   Pinnell SR, Yang H, Omar M, Monteiro-Riviere N, DeBuys HV, Walker LC, Wang Y, Levine M · Dermatologic Surgery 27(2):137-42 · 2001

2. 2

   Chemical Stability of Ascorbic Acid Integrated into Commercial Products: A Review on Bioactivity and Delivery Technology

   Yin X, Chen K, Cheng H, Chen X, Feng S, Song Y, Liang L · Antioxidants (Basel) · 2022

3. 3

   Topical Vitamin C and the Skin: Mechanisms of Action and Clinical Applications

   Al-Niaimi F, Chiang NYZ · Journal of Clinical and Aesthetic Dermatology 10(7):14-17 · 2017

4. 4

   Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin

   Bissett DL, Miyamoto K, Sun P, Li J, Berge CA · International Journal of Cosmetic Science 26(5):231-238 · 2004

5. 5

   Niacinamide: A B vitamin that improves aging facial skin appearance

   Bissett DL, Oblong JE, Berge CA · Dermatologic Surgery 31(7 Pt 2):860-5 · 2005

6. 6

   The effect of 2% niacinamide on facial sebum production

   Draelos ZD, Matsubara A, Smiles K · Journal of Cosmetic and Laser Therapy 8(2):96-101 · 2006

7. 7

   Final report of the safety assessment of niacinamide and niacin

   Cosmetic Ingredient Review Expert Panel · International Journal of Toxicology 24 Suppl 5:1-31 · 2005